| ||||||||||||||
|
|
|||||||||||||



*Clinical Assistant Professor of Oral Surgery; Resident in Anesthesiology, North Carolina Memorial Hospital.
Professor and Chairman, Department of Oral Surgery. University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514.
Associate Professor, Department of Medicine. University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514.
Associate Professor and Vice Chairman, Department of Anesthesiology. University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514.
||Medical Intern, The Medical College of South Carolina, Charleston, South Carolina. University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514.
University of North Carolina School of Medicine, Chapel Hill, North Carolina 27514.
Abstract
Hepatitis from halothane is usually diagnosed by excluding other possible causes. Whether preexisting hepatic damage, which can occur in certain autoimmune disorders, contraindicates the use of halothane has yet to be proven. The case of a 14-year-old boy with early-onset juvenile rheumatoid arthritis who developed fatal hepatic necrosis 13 days after halothane anesthesia is presented.
|